Antisense Pharma GmbH
10Patents
9Active
10Granted
47Portfolio score
Filing activity: Apr 22, 2003 → Sep 28, 2012 · 8 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| USD709183S1 | Pump for pharmaceutical and cosmetic products | General | 132 | Active |
| US8936910B2 | Method for selective oligonucleotide modification | Chemistry; Metallurgy | 51 | Active |
| USD697204S1 | Pump for pharmaceutical and cosmetics products | General | 30 | Active |
| US7963956B2 | Portable equipment for administration of fluids into tissues and tumors by convection enhanced delivery technique | Human Necessities | 29 | Active |
| US8177775B2 | Portable equipment for administration of fluids into tissues and tumors by convection enhanced delivery technique | Human Necessities | 18 | Active |
| US8476246B2 | Combination of a chemotherapeutic agent and an inhibitor of the TGF-beta system | Chemistry; Metallurgy | 6 | Active |
| US8822425B2 | Dosage of oligonucleotides suitable for the treatment of tumors | Chemistry; Metallurgy | 2 | Active |
| US8097597B2 | Use of low doses of oligonucleotides antisense to TGF-β genes in the treatment of brain tumors | Chemistry; Metallurgy | 2 | Active |
| US7910563B2 | Antisense oligonucleotide to inhibit melanoma inhibitory activity, MIA | Chemistry; Metallurgy | 0 | Expired |
| US8148493B2 | Method for inhibiting “melanoma inhibitory activity” MIA | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.